The National Forensic Laboratory Information System (NFLIS) is a Drug Enforcement Administration (DEA) program that systematically collects drug chemistry analysis results, as well as other related information, from cases analyzed by state, local and federal forensic laboratories. These laboratories analyze substances secured in law enforcement operations across the country. NFLIS offers a valuable resource for monitoring illegal drug abuse and trafficking, including the diversion of legally manufactured pharmaceutical drugs into illegal markets. NFLIS data are used to support drug regulatory and scheduling efforts as well as to inform drug policy and drug enforcement initiatives both nationally and in local communities.
Since its inception in September 1997, NFLIS has become an operational information system that includes data from forensic laboratories that conduct analyses of about 97% of the nation's approximate 1.5 million annual drug cases. As of June 2018, state and local forensic laboratory systems representing a total of 282 (109 local and 173 state) individual labs were participating in NFLIS. Of these, 273 individual laboratories (101 local and 172 state) were regularly reporting data to NFLIS; the remaining participating labs are in the process of initiating data reporting. DEA continues to recruit state and local forensic laboratories that conduct drug chemistry analyses with a goal of 100% participation and reporting.
NFLIS Program Expansion
Over the next few years, the NFLIS program will expand to include two additional continuous drug surveillance programs that collect drug-related mortality data from medical examiner and coroner offices (NFLIS-MEC) and drug testing results from toxicology laboratories (NFLIS-Tox) to supplement and complement the current information from drug cases submitted to and analyzed by the Nation’s forensic laboratories (NFLIS-Drug).
In 2017, DEA conducted the NFLIS Medical Examiner/Coroner Office Survey and the NFLIS Toxicology Laboratory Survey. The information gathered from these two surveys will inform the NFLIS-MEC and NFLIS-Tox surveillance systems that will be launched in 2018. Results from these two surveys will be released via reports that provide aggregated statistics, as DEA has done with the NFLIS Survey of Crime Laboratory Drug Chemistry Sections (e.g., see the 2013 report). If any medical examiner/coroner office or toxicology laboratory wishes to complete a survey, but was unable to do so before the survey closed in October 2017, please contact us at NFLISSupport@deaecom.gov. The DEA would be glad to accept your data for inclusion in the universe of offices and laboratories for use in future NFLIS activities.